Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis

被引:0
|
作者
Ahmed, T. Said [1 ]
Al-Sarie, M. [2 ]
Srour, K. [2 ]
Rygielski, S. [3 ]
Ye, F. [2 ]
Hernandez, D. [4 ]
机构
[1] Univ Toledo, Crit Care Pulm, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Univ Toledo, Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Univ Toledo, Anesthesia, 2801 W Bancroft St, Toledo, OH 43606 USA
[4] Univ Toledo, Med Ctr, Pulm Crit Care Sleep Med, 2801 W Bancroft St, Toledo, OH 43606 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3045
引用
收藏
页数:2
相关论文
共 50 条
  • [41] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247
  • [42] CAPTAIN: Effects of Adding the Long-Acting Muscarinic Antagonist Umeclidinium to Inhaled Corticosteroid/Long-Acting Beta2-Agonist Therapy on Symptoms in Patients with Inadequately Controlled Asthma
    Gardiner, F.
    Pizzichini, E.
    Pavord, I
    Brusselle, G.
    Oppenheimer, J.
    Kerstjens, H.
    Papi, A.
    Inoue, H.
    Tabberer, M.
    Fowler, A.
    Slade, D.
    Bailes, Z.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [43] Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Price, David
    Bousquet, Jean
    RESPIRATORY MEDICINE, 2012, 106 : S4 - S8
  • [44] Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients: Exacerbation risk assessment
    Yang, Sheau-Ning
    Ko, Hsin-Kuo
    Hsiao, Yi-Han
    Su, Kang-Cheng
    Chang, Yuh-Lih
    Huang, Hsin-Yi
    Perng, Diahn-Warng
    Chung, Mei-Ing
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 488 - 494
  • [45] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Gary T. Ferguson
    Patrick Darken
    Shaila Ballal
    Mohd Kashif Siddiqui
    Barinder Singh
    Sumeet Attri
    Ulf Holmgren
    Enrico de Nigris
    Advances in Therapy, 2020, 37 : 2956 - 2975
  • [46] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Ferguson, Gary T.
    Darken, Patrick
    Ballal, Shaila
    Siddiqui, Mohd Kashif
    Singh, Barinder
    Attri, Sumeet
    Holmgren, Ulf
    de Nigris, Enrico
    ADVANCES IN THERAPY, 2020, 37 (06) : 2956 - 2975
  • [47] Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD
    Demir, Tuncalp
    Gunen, Hakan
    Polatli, Mehmet
    Yildirim, Nurhayat
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2011, 59 (01): : 89 - 100
  • [48] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
    Fukuda, Nobuhiko
    Horita, Nobuyuki
    Kaneko, Ayami
    Goto, Atsushi
    Kaneko, Takeshi
    Ota, Erika
    Kew, Kayleigh M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [49] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
    Mapel, Douglas W.
    Hurley, Judith S.
    Dalal, Anand A.
    Blanchette, Christopher M.
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103
  • [50] Optimal Bronchodilation for COPD Patients: Are All Long-Acting beta(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
    Miravitlles, Marc
    Baek, Seungjae
    Vithlani, Vatsal
    Lad, Rahul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (03) : 198 - 215